| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000039708 |
| Receipt No. | R000045287 |
| Scientific Title | Study for the effects of molecular hydrogen on the cytokine and oxidative stress levels in pregnant women |
| Date of disclosure of the study information | 2020/04/01 |
| Last modified on | 2020/03/05 (Ver. 1) |
| Basic information | ||
| Public title | Study for the effects of molecular hydrogen on the cytokine and oxidative stress levels in pregnant women | |
| Acronym | Effects of molecular hydrogen on pregnancy | |
| Scientific Title | Study for the effects of molecular hydrogen on the cytokine and oxidative stress levels in pregnant women | |
| Scientific Title:Acronym | Effects of molecular hydrogen on pregnancy | |
| Region |
|
|
| Condition | ||
| Condition | pregnant women | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the relationship of maternal molecular hydrogen intake to cytokines and oxidative stress |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the relationship of maternal molecular hydrogen intake to cytokines and oxidative stress, especially pro-inflammatory cytokines and 8OHdG |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To investigate the relationship of molecular hydrogen intake to cytokines and oxidative stress in pregnant women |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingest a hydrogen-containing beverage that is licensed and commercial available as a health food. The intake should be 200-300mL / time x 1-3 times / day in principle. Therefore, the longest intake period is about 24 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | All pregnant women over than or equal to 16 gestational-age and minimum age of 20 years | |||
| Key exclusion criteria | Pregnant women, considered unsuitable for participation in this study by the investigators | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya University Graduate School of Medicine | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya, Japan | ||||||
| TEL | 052-744-2261 | ||||||
| kenchan2@med.nagoya-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya University Graduate School of Medicine | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya, Japan | ||||||
| TEL | 052-744-2261 | ||||||
| Homepage URL | |||||||
| kenchan2@med.nagoya-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MEXT |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Nagoya University Graduate School of Medicine |
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya, Japan |
| Tel | 052-744-2479 |
| iga-shinsa@adm.nagoya-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045287 |